High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease.

Patients with acquired von Willebrand disease may present with severe bleeding, which is usually difficult to manage. Adequate haemostasis in acquired von Willebrand disease may be achieved with the infusion of factor VIII/von Willebrand factor concentrates or with the administration of desmopressin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Van Genderen, P. J., Papatsonis, D. N., Michiels, J. J., Wielenga, J. J., Stibbe, J., Huikeshoven, F. J.
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 1994
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2398043/
https://ncbi.nlm.nih.gov/pubmed/7532860
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars